TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.30$ +0.8% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

InterCure Ltd. (INCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at 17 million ILS. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Cash Flow INCR
Line item Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q1 25 Q2 25 Q3 25 Q1 26 LTM
43 -53 0.9 – – -22 -22 – 6.1 6.1 2.3 17 31
4.4 3.2 0.9 – – 3.2 3.2 – 4.2 4.2 4.3 4.3 17
2.7 1.4 0.9 0.1 – 0.3 0.3 0.8 0.4 0.4 0.8 0.8 2.4
3.6 3.6 – – – – – – – – – – –
52 -59 0.3 – – -23 -23 – -7.5 -7.5 21 21 28
4.7 0.7 0.0 0.0 0.0 0.2 0.2 0.0 1.6 1.6 0.2 3.5 6.9
-14 -14 – – – 5.5 5.5 – -2.2 -2.2 1.2 -2.0 -5.2
0.0 0.0 – – – – – – – – – – –
-55 -55 – – – – – – – – – – –
37 -59 – – – -24 -24 – -17 -17 -5.9 -47 -87
18 -126 0.9 – – – – – – – – -32 –
38 -53 0.9 – – -22 -22 – 4.5 4.5 2.2 13 24

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?